Search

Aniko M Redman

age ~57

from Durham, NC

Get Report
Also known as:
  • Aniko Maria Redman
  • Aniko Redmen
Phone and address:
31 Westridge Dr, Durham, NC 27713
9199735536
Related to:
Connected to:

Aniko Redman Phones & Addresses

  • 31 Westridge Dr, Durham, NC 27713 • 9199735536
  • 1001 Goldenview Ct, Durham, NC 27713 • 9195447437
  • Hillsborough, NC
  • 66 E E St, Derby, CT 06418 • 2037346107
  • Hamden, CT
  • College Sta, TX
  • Graham, NC

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    Associate degree or higher

Us Patents

  • Inhibition Of Raf Kinase Using Aryl And Heteroaryl Substituted Heterocyclic Ureas

    view source
  • US Patent:
    7329670, Feb 12, 2008
  • Filed:
    Dec 27, 1999
  • Appl. No.:
    09/472232
  • Inventors:
    Jacques Dumas - Orange CT, US
    Uday Khire - Hamden CT, US
    Timothy B. Lowinger - Nishinomiya, JP
    Bernard Riedl - Branford CT, US
    William J. Scott - Guilford CT, US
    Roger A. Smith - Madison CT, US
    Jill E. Wood - Hamden CT, US
    Holia Hatoum-Mokdad - Hamden CT, US
    Jeffrey Johnson - Branford CT, US
    Aniko Redman - Derby CT, US
    Robert Sibley - North Haven CT, US
  • Assignee:
    Bayer Pharmaceuticals Corporation - West Haven CT
  • International Classification:
    C07D 231/38
    C07D 403/12
    A61K 31/415
  • US Classification:
    514275, 514333, 514341, 514407, 544333, 546256, 5462754, 5483717
  • Abstract:
    The compounds are aryl and heteroaryl substituted heterocyclic ureas of the formula A—NH—C(O)—NH—B where A is the aryl or hetaryl substituted heterocyclic group and B is an aryl or heteroaryl moiety. The compounds inhibit raf kinase and are useful in the treatment of RAF kinase mediated diseases.

  • Cyanopyridine Derivatives Useful In The Treatment Of Cancer And Other Disorders

    view source
  • US Patent:
    7557129, Jul 7, 2009
  • Filed:
    Feb 27, 2004
  • Appl. No.:
    10/788029
  • Inventors:
    William J. Scott - Guilford CT, US
    Jacques Dumas - Bethany CT, US
    Stephen Boyer - Hilden, DE
    Wendy Lee - Hamden CT, US
    Yuanwei Chen - North Haven CT, US
    Barton Phillips - New Haven CT, US
    Sharad Verma - New Haven CT, US
    Jianqing Chen - New Haven CT, US
    Zhi Chen - Hamden CT, US
    Jianmei Fan - Hamden CT, US
    Brian Raudenbush - Charlton MA, US
    Aniko Redman - Derby CT, US
    Lin Yi - Milford CT, US
    Qingming Zhu - West Haven CT, US
    Lila Adnane - Madison CT, US
  • Assignee:
    Bayer Healthcare LLC - Tarrytown NY
  • International Classification:
    A61K 31/4433
    C07D 405/12
  • US Classification:
    514338, 5462837
  • Abstract:
    This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.

  • Inhibition Of Raf Kinase Using Aryl And Heteroaryl Substituted Heterocyclic Ureas

    view source
  • US Patent:
    7625915, Dec 1, 2009
  • Filed:
    Jun 26, 2007
  • Appl. No.:
    11/768533
  • Inventors:
    Jacques Dumas - Orange CT, US
    Uday Khire - Hamden CT, US
    Timothy B. Lowinger - Nishinomiya, JP
    Bernard Riedl - Branford CT, US
    William J. Scott - Guilford CT, US
    Roger A. Smith - Madison CT, US
    Jill E. Wood - Hamden CT, US
    Holia Hatoum-Mokdad - Hamden CT, US
    Jeffrey Johnson - Branford CT, US
    Aniko Redman - Derby CT, US
    Robert Sibley - North Haven CT, US
  • Assignee:
    Bayer HealthCare LLC - Tarrytown NY
  • International Classification:
    A61K 31/415
    C07D 231/38
    C07D 403/12
  • US Classification:
    514275, 514333, 514341, 514407, 544333, 546256, 5462754, 5483717
  • Abstract:
    Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

  • 2-[2-{Phenylamino}-1H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Amino] Benzamide Derivatives As Igf-1R Inhibitors For The Treatment Of Cancer

    view source
  • US Patent:
    7981903, Jul 19, 2011
  • Filed:
    Aug 6, 2008
  • Appl. No.:
    12/671960
  • Inventors:
    Stanley Dawes Chamberlain - Chapel Hill NC, US
    Felix Deanda, Jr. - Durham NC, US
    Roseanne Gerding - Durham NC, US
    Masaichi Hasegawa - Tsukuba, JP
    Kevin Kuntz - Durham NC, US
    Huangshu Lei - Durham NC, US
    Yasushi Miyazaki - Tsukuba, JP
    Naohiko Nishigaki - Tsukuba, JP
    Samarjit Patnaik - Durham NC, US
    Aniko Redman - Durham NC, US
    John Brad Shotwell - Durham NC, US
    Kirk Stevens - Durham NC, US
    Joseph Wilson - Durham NC, US
    Bin Yang - Durham NC, US
  • Assignee:
    GlaxoSmithKline LLC - Philadelphia PA
  • International Classification:
    A01N 43/90
    A61K 31/519
    C07D 487/00
  • US Classification:
    5142651, 544280
  • Abstract:
    Novel pyrrolopyrimidines as shown in formula (I):.

  • Bicyclic Urea Derivatives Useful In The Treatment Of Cancer And Other Disorders

    view source
  • US Patent:
    8076488, Dec 13, 2011
  • Filed:
    Mar 1, 2004
  • Appl. No.:
    10/788426
  • Inventors:
    Jacques Dumas - Bethany CT, US
    Stephen Boyer - Fairfield CT, US
    Sharad Verma - New Haven CT, US
    Lila Adnane - Madison CT, US
    Yuanwei Chen - North Haven CT, US
    Wendy Lee - Hamden CT, US
    Barton Phillips - New Haven CT, US
    Roger A. Smith - Madison CT, US
    William J. Scott - Guildford CT, US
    Jennifer Burke - New Haven CT, US
    Jianqing Chen - New Haven CT, US
    Zhi Chen - Hamden CT, US
    Jianmei Fan - Hamden CT, US
    Karl Miranda - North Haven CT, US
    Brian Raudenbush - Charlton MA, US
    Aniko Redman - Derby CT, US
    Jianxing Shao - Acton MA, US
    Ning Su - Hamden CT, US
    Gan Wang - Wallingford CT, US
    Lin Yi - Milford CT, US
    Qingming Zhu - West Haven CT, US
  • Assignee:
    Bayer Healthcare LLC - Tarrytown NY
  • International Classification:
    C07D 213/62
    C07D 401/00
    C07D 417/00
  • US Classification:
    546298, 5462701, 5462757, 544365, 544373
  • Abstract:
    This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.

  • Substituted 2,3-Dihydroimidazo[1,2-C]Quinazoline Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis

    view source
  • US Patent:
    8466283, Jun 18, 2013
  • Filed:
    Dec 5, 2007
  • Appl. No.:
    12/517875
  • Inventors:
    Martin Hentemann - Carlisle CT, US
    Jill Wood - Fort Collins CO, US
    William Scott - Guilford CT, US
    Martin Michels - Kölne, DE
    Ann-Marie Campbell - Monroe CT, US
    Ann-Marie Bullion - Milford CT, US
    Bruce R. Rowley - New Hope PA, US
    Aniko Redman - Durham NC, US
  • Assignee:
    Bayer Intellectual Property GmbH - Monheim
  • International Classification:
    C07D 491/00
  • US Classification:
    544250
  • Abstract:
    This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

  • Inhibition Of P38 Kinase Activity By Aryl Ureas

    view source
  • US Patent:
    20020103253, Aug 1, 2002
  • Filed:
    Sep 7, 2001
  • Appl. No.:
    09/947761
  • Inventors:
    Gerald Ranges - Humden CT, US
    William Scott - Guilford CT, US
    Michael Bombara - Hamden CT, US
    Deborah Rauner - Sandy Hook CT, US
    Aniko Redman - Derby CT, US
    Roger Smith - Madison CT, US
    Holger Paulsen - Wuppertal, DE
    David Gunn - Hamden CT, US
    Jinshan Chen - Hamden CT, US
    Joel Renick - West Haven CT, US
  • Assignee:
    BAYER CORPORATION - Pittsburgh PA
  • International Classification:
    A61K031/40
    A61K031/381
    A61K031/34
  • US Classification:
    514/426000, 514/447000, 514/472000, 514/423000
  • Abstract:
    This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

  • 17-Beta-Hydroxysteroid Dehydrogenase-Ii Inhibitors

    view source
  • US Patent:
    20030087952, May 8, 2003
  • Filed:
    Sep 28, 2001
  • Appl. No.:
    09/967430
  • Inventors:
    Jill Wood - North Haven CT, US
    Jeremy Baryza - Mountain View CA, US
    Catherine Brennan - Hamden CT, US
    Soongyu Choi - Trumbull CT, US
    James Cook - East Hampton CT, US
    Brian Dixon - Woodbridge CT, US
    Paul Ehrlich - Duesseldorf-Wittlaer, DE
    David Gunn - Hamden CT, US
    Ian McAlexander - Pocatello ID, US
    Peiying Liu - Madison CT, US
    Derek Lowe - Hamden CT, US
    Aniko Redman - Derby CT, US
    William Scott - Guilford CT, US
    Yamin Wang - Sandy Hook CT, US
  • International Classification:
    A61K031/4015
    C07D207/46
    C07D207/48
  • US Classification:
    514/424000, 548/542000
  • Abstract:
    17-beta-hydroxysteroid dehydrogenase-I1 inhibitors having the structural formula wherein the phenyl group labeled A and the group —C(R)(R)Y are oriented cis to each other; W represents 0 or S; Rrepresents —H or optionally substituted —(C-C)alkyl; n represents 0 or an integer of 1-3; and Rrepresents any of a variety of substituents on ring A. Rgenerally represents —H but may be a bond terminating at the ortho position of ring A. Y represents fluorine, —OR, or —SR, and Rrepresents —H. optionally substituted —(C-C)alkyl, optionally substituted -phenyl, optionally substituted —(C-C)alkyl-phenyl, or optionally substituted —(C-C)acyl. Rrepresents any of a variety of groups as defined in the specification and claims, including heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, alkynyl, arylalkynyl, heteroarylalkynyl, aryl, and indolyl. Pharmaceutically acceptable salts and N-oxides of these materials are also included. Also claimed are pharmaceutical compositions containing these materials and methods of using them.
Get Report for Aniko M Redman from Durham, NC, age ~57
Control profile